Back to search
Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer (SCLC): Preliminary safety and efficacy results from KEYNOTE-028.
Data up to Jan 2025
Published2015
Citations86
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database